Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.

Saved in:
Bibliographic Details
Title: Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.
Authors: Rajdev L; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Jackie Wang CC; UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California, USA., Joshi H; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lensing S; St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Lee J; University of Arkansas for Medical Sciences, Little Rock, Alaska, USA., Ramos JC; University of Miami Sylvester Cancer Center, Miami, Florida, USA., Baiocchi R; Ohio State University James Comprehensive Cancer Center, Columbus, Ohio, USA., Ratner L; Washington University, St. Louis, Missouri, USA., Rubinstein PG; Division of Hematology/Oncology, Stroger Hospital of Cook County (Cook County Hospital), Ruth M. Rothstein Core Center, University of Illinois, Chicago, Illinois, USA., Ambinder R; Johns Hopkins Univ-Sidney Kimmel Cancer Center, Baltimore, Maryland, USA., Henry D; Pennsylvania Hospital, Philadelphia, Pennsylvania, USA., Streicher H; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA., Chiao E; MD Anderson Cancer Center, Houston, Texas, USA., Dittmer DP; University of North Carolina, Chapel Hill, North Carolina, USA., Einstein MH; Rutgers New Jersey Medical School, Newark, New Jersey, USA., Cesarman E; Weill Cornell Medicine, New York, New York, USA., Mitsuyasu R; University of California Los Angeles Care Center, Los Angeles, California, USA., Sparano JA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Corporate Authors: AIDS Malignancy Consortium
Source: Cancer [Cancer] 2024 Mar 15; Vol. 130 (6), pp. 985-994. Date of Electronic Publication: 2023 Nov 14.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0142
DOI:10.1002/cncr.35110